Bharat Biotech submits intranasal vaccine data to drug regulator, says vax safe and immunogenic |…
HYDERABAD: Bharat Biotech International Limited(BBIL) on Monday said its intranasal Covid-19 vaccine BBV154 has proved to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials for the vaccine as a primary…